U.S. markets closed

CymaBay Therapeutics, Inc. (CBAY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
32.20+0.02 (+0.06%)
At close: 04:00PM EST
32.13 -0.07 (-0.22%)
After hours: 06:38PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Up

Gap Up

Previous Close32.18
Bid32.15 x 4000
Ask32.24 x 3100
Day's Range32.14 - 32.20
52 Week Range7.26 - 32.24
Avg. Volume3,487,585
Market Cap3.696B
Beta (5Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)-0.93
Earnings DateMar 14, 2024 - Mar 18, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CBAY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CymaBay Therapeutics Inc.
    Daily – Vickers Top Buyers & Sellers for 01/21/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more